Citius Oncology CTOR Balance Sheet (2021-2026)

NASDAQ CTOR
$0.94 +0.01 (+1.17%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Citius Oncology Quarterly Balance Sheet

Periods 17 quarters
Latest Jun 2026

Citius Oncology reported total assets of $112.09M and total liabilities of $71.71M for the quarter ended Jun 2026, up 22.2% year over year. This balance sheet covers 17 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2021 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 0.29M0.12M0.37M0.25M0.03M0.25M0.25M112.00112.00112.00112.003.92M7.30M2.63M16.56M
Receivables - NetNet Receivables 4.05M1.08M0.69M
Receivables 4.05M1.08M0.69M
Work In Process 2.13M11.71M6.95M6.95M6.95M
Finished Goods 6.13M10.58M15.69M15.71M15.67M
Inventory 8.27M14.38M15.34M17.21M22.29M22.64M22.66M22.63M
Prepaid Assets 0.09M0.12M0.09M7.73M0.03M0.06M0.04M2.70M2.70M2.70M1.10M1.33M3.16M3.05M2.83M
Current Assets 0.13M0.38M0.25M0.46M7.73M0.06M0.09M0.04M10.97M17.08M18.04M18.31M27.54M37.15M29.42M42.71M
Non-Current Assets
Long-Term Investments 67.81M68.57M69.39M70.63M72.57M48.58M49.15M
Intangibles 73.40M72.83M73.40M73.40M
Goodwill & Intangibles 73.40M72.83M73.40M73.40M
Long-Term Deferred Tax 4.65M7.53M
Other Non-Current Assets 0.13M0.26M40.00M73.40M73.40M73.40M73.40M73.40M72.83M71.28M69.39M
Non-Current Assets 67.81M68.57M69.39M40.00M72.57M48.58M49.15M73.40M73.40M73.40M73.40M73.40M72.83M71.28M69.39M
Assets 0.13M0.26M68.19M68.82M69.85M47.73M72.62M48.68M49.19M84.37M90.48M91.44M91.71M100.94M109.97M100.70M112.09M
Liabilities
Current Liabilities
Accounts Payables 1.29M3.71M5.87M7.68M8.67M13.23M10.45M8.88M7.32M
Notes Payables 0.13M0.19M1.32M1.52M1.72M3.80M3.80M3.80M3.80M3.80M3.80M
Payables 0.13M0.19M1.29M1.32M1.52M1.72M7.51M9.67M11.48M12.47M17.03M14.25M8.88M7.32M
Accumulated Expenses 0.11M0.26M0.38M0.49M0.49M6.23M8.72M8.46M4.09M4.52M24.06M25.84M
Other Accumulated Expenses 0.35M19.50M0.34M0.54M0.87M0.59M2.90M4.94M7.46M9.51M11.49M8.22M9.99M
Total Current Liabilities 0.14M0.27M0.03M0.05M0.46M21.05M2.05M2.82M3.08M32.70M43.40M49.74M52.99M49.49M44.71M58.81M58.79M
Non-Current Liabilities
Capital Leases 6.41M
Non-Current Debt 3.80M3.80M3.80M
Preferred Stock Liabilities 67.81M68.57M69.39M70.63M72.57M48.32M49.15M
Non-Current Deferred Tax Liability 1.15M1.73M1.99M2.26M2.52M2.78M3.05M2.82M2.71M
Other Non-Current Liabilities 0.56M0.56M0.56M0.56M0.56M0.56M
Total Non-Current Liabilities 48.63M55.24M58.75M55.52M51.00M64.87M
Total Liabilities 0.14M-36.01M67.84M68.62M69.85M22.20M49.90M28.83M32.16M38.23M49.19M55.80M59.31M56.08M51.56M65.43M71.71M
Shareholder's Equity
Total Debt 0.13M0.19M1.32M1.52M1.72M3.80M3.80M3.80M3.80M7.60M3.80M3.80M3.80M
Common Equity -0.01M36.27M0.35M0.20M-0.00M25.54M22.73M19.85M17.03M46.14M41.29M35.64M32.40M44.87M58.41M35.27M40.38M
Liabilities and Shareholders Equity 0.13M0.26M68.19M68.82M69.85M47.73M72.62M48.68M49.19M84.37M90.48M91.44M91.71M100.94M109.97M100.70M112.09M
Retained Earnings 0.02M0.02M0.35M0.20M-0.00M43.66M-1.99M-2.46M-3.04M85.41M87.22M89.31M91.43M108.90M127.98M131.44M145.48M
Treasury Shares 6.60M6.60M6.60M6.60M6.60M6.60M4.31M4.31M